Nuvectis Pharma (NVCT) Stock Forecast for 2023 – 2026. Sell or Buy Prediction







Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

Nuvectis Pharma (NVCT) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: February 24, 2024 (06:25)

Sector: Healthcare

The share price of Nuvectis Pharma, Inc. (NVCT) now

Latest session on the 23rd of February for
Nuvectis Pharma, Inc. is positive
Trading Volume: 86514
Open: 7.32 /  High: 7.85 /  Low: 7.17
What analysts predict: $20.67
52-week High/Low: $18.65 / $6.2

50/200 Day Moving Average: $8.04 / $12.13

This figure corresponds to the Average Price over the previous 50/200 days. For Nuvectis Pharma stocks, the 50-day moving average is the resistance level today.

For Nuvectis Pharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Nuvectis Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nuvectis Pharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one Nuvectis Pharma share be worth in 2024 - 2028?

When should I take profit in Nuvectis Pharma stock? When should I record a loss on Nuvectis Pharma stock? What are analysts' forecasts for Nuvectis Pharma stock? What is the future of Nuvectis Pharma stock? We forecast Nuvectis Pharma stock performance using neural networks based on historical data on Nuvectis Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Nuvectis Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Nuvectis Pharma shares. This happens once a day.


Historical and forecast chart of Nuvectis Pharma stock

The chart below shows the historical price of Nuvectis Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Nuvectis Pharma stock price can be found in the table below.

Long-term forecasts by years.

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.

Nuvectis Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 26 7.69 7.37 8.01 8.71
Feb 27 7.70 7.47 8.02 7.36
Feb 28 7.51 7.36 7.86 6.86
Feb 29 7.09 6.78 7.22 6.53
Mar 01 7.16 6.99 7.39 5.66
Mar 02 7.51 7.40 7.75 4.69
Mar 03 7.51 7.31 7.64 4.44
Mar 04 7.62 7.32 7.82 6.81
Mar 05 7.79 7.66 7.89 2.93
Mar 06 7.38 7.25 7.69 6.05
Mar 07 7.49 7.28 7.68 5.55
Mar 08 7.35 7.13 7.67 7.67
Mar 09 7.64 7.32 7.84 7.21
Mar 10 7.78 7.67 8.06 5.11
Mar 11 7.99 7.88 8.09 2.68
Mar 12 7.86 7.67 8.08 5.28
Mar 13 8.13 7.98 8.47 6.12
Mar 14 8.32 8.04 8.60 6.95
Mar 15 8.39 8.23 8.56 4.04
Mar 16 8.44 8.30 8.72 5.13
Mar 17 8.55 8.14 8.83 8.51
Mar 18 8.74 8.39 9.08 8.18
Mar 19 9.07 8.82 9.25 4.94
Mar 20 8.91 8.62 9.25 7.32
Mar 21 9.43 9.05 9.66 6.69
Mar 22 9.56 9.22 9.71 5.22
Mar 23 9.46 9.11 9.72 6.67
Mar 24 9.41 9.12 9.79 7.37
Mar 25 9.02 8.75 9.24 5.63
Mar 26 8.80 8.47 8.91 5.11

Nuvectis Pharma Daily Price Targets


Nuvectis Pharma Stock Forecast 02-26-2024.

Forecast target price for 02-26-2024: $7.69.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 8.008%.
Pessimistic target level: 7.37
Optimistic target level: 8.01

Nuvectis Pharma Stock Forecast 02-27-2024.

Forecast target price for 02-27-2024: $7.70.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.856%.
Pessimistic target level: 7.47
Optimistic target level: 8.02

Nuvectis Pharma Stock Forecast 02-28-2024.

Forecast target price for 02-28-2024: $7.51.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.416%.
Pessimistic target level: 7.36
Optimistic target level: 7.86

Nuvectis Pharma Stock Forecast 02-29-2024.

Forecast target price for 02-29-2024: $7.09.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.126%.
Pessimistic target level: 6.78
Optimistic target level: 7.22

Nuvectis Pharma Stock Forecast 03-01-2024.

Forecast target price for 03-01-2024: $7.16.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.353%.
Pessimistic target level: 6.99
Optimistic target level: 7.39

Nuvectis Pharma Stock Forecast 03-02-2024.

Forecast target price for 03-02-2024: $7.51.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 4.480%.
Pessimistic target level: 7.40
Optimistic target level: 7.75

NVCT (NVCT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Mar. 7.57 6.81 8.67 21.47
Apr. 8.91 7.79 9.45 17.55
May. 9.48 8.70 10.49 17.00
Jun. 9.54 8.09 10.53 23.19
Jul. 8.91 8.37 9.91 15.47
Aug. 10.14 9.25 11.44 19.15
Sep. 12.15 10.69 13.17 18.82
Oct. 12.20 10.63 12.95 17.89
Nov. 13.41 12.50 15.35 18.53
Dec. 13.36 11.49 14.22 19.17

Nuvectis Pharma forecast for this year


Nuvectis Pharma Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $7.56512. Pessimistic: $6.81. Optimistic: $8.67


Nuvectis Pharma Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $8.91171. Pessimistic: $7.79. Optimistic: $9.45


Nuvectis Pharma Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $9.48206. Pessimistic: $8.70. Optimistic: $10.49


Nuvectis Pharma Stock Prediction for Jun 2024

An uptrend is forecast for this month with an optimal target price of $9.53895. Pessimistic: $8.09. Optimistic: $10.53


Nuvectis Pharma Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $8.90938. Pessimistic: $8.37. Optimistic: $9.91


Nuvectis Pharma Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $10.1389. Pessimistic: $9.25. Optimistic: $11.44


Nuvectis Pharma Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $12.1464. Pessimistic: $10.69. Optimistic: $13.17


Nuvectis Pharma Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $12.195. Pessimistic: $10.63. Optimistic: $12.95


Nuvectis Pharma Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $13.4145. Pessimistic: $12.50. Optimistic: $15.35


Nuvectis Pharma Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $13.3608. Pessimistic: $11.49. Optimistic: $14.22



Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 10.74 10.31 11.56 10.78
Feb 10.08 9.17 11.33 19.04
Mar 11.02 10.38 11.77 11.80
Apr 10.23 9.74 11.29 13.77
May 11.83 9.93 12.87 22.79
Jun 14.19 13.14 15.10 12.97
Jul 15.13 13.19 16.52 20.15
Aug 16.31 14.15 17.71 20.07
Sep 18.07 15.32 20.53 25.35
Oct 15.72 14.15 17.10 17.28
Nov 16.16 13.80 18.74 26.38
Dec 14.87 13.53 15.85 14.63

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 14.90 13.14 15.52 15.35
Feb 17.88 17.02 20.13 15.45
Mar 16.09 14.87 18.12 17.94
Apr 17.34 14.85 18.45 19.55
May 17.69 15.35 20.52 25.17
Jun 19.39 18.03 22.30 19.13
Jul 21.13 20.16 23.80 15.28
Aug 19.36 18.47 20.87 11.50
Sep 17.11 15.88 18.00 11.79
Oct 17.32 15.10 19.19 21.30
Nov 20.50 17.76 22.68 21.70
Dec 21.28 20.30 23.37 13.11

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 20.30 19.45 21.64 10.13
Feb 20.99 19.40 23.43 17.20
Mar 19.40 16.95 21.80 22.24
Apr 20.45 17.22 21.26 19.04
May 24.29 22.49 25.46 11.64
Jun 23.71 20.06 26.65 24.73
Jul 26.03 23.79 29.47 19.26
Aug 24.99 23.84 26.74 10.84
Sep 26.09 22.65 27.60 17.96
Oct 27.65 26.44 31.75 16.72
Nov 33.07 28.51 35.65 20.04
Dec 31.95 29.39 36.55 19.58

Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 31.31 26.93 36.13 25.48
Feb 28.62 25.41 33.03 23.05
Mar 30.79 25.87 35.35 26.83
Apr 28.70 25.54 32.03 20.25
May 33.87 28.45 35.42 19.69
Jun 29.60 27.70 33.03 16.13
Jul 29.84 25.24 33.59 24.87
Aug 29.18 25.74 32.15 19.96
Sep 25.44 23.76 27.63 14.00
Oct 23.41 19.71 26.64 26.01
Nov 24.39 20.73 26.49 21.73
Dec 23.12 20.67 25.34 18.43

Nuvectis Pharma information and performance

Nuvectis Pharma Address

1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, US

Market Capitalization: 130 296 000 $

Market capitalization of the Nuvectis Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of NVCT shares in the company outstanding by the market price of one share.

EBITDA: - $

EBITDA of Nuvectis Pharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.5

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -4.753

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 17326600

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.